CAXTON CORP Diversified Active

Location: Princeton, NJ

CIK: 0001388551 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 14, 2025

Total Value: $22.86M (100.0% shares, 0.0% debt)

Holdings (12)

RZLT REZOLUTE INC 81.7%

Value $18.68M Shares 1,986,818 Share Price $9.40 * Est. Cost/Share $8.14 Unrealized @ Report Date -18.2%

GLD SPDR GOLD TR 11.3%

Value $2.59M Shares 7,286 Share Price $355.47 Est. Cost/Share $310.70 Unrealized @ Report Date —

BRK/B BERKSHIRE HATHAWAY INC DEL 1.4%

Value $327K Shares 651 Share Price $503.00 * Est. Cost/Share $401.81 Unrealized @ Report Date +20.5%

— MIND MEDICINE MINDMED INC 1.4%

Value $318K Shares 27,011 Share Price $11.79 Est. Cost/Share $8.91 Unrealized @ Report Date —

ELVN ENLIVEN THERAPEUTICS INC 1.2%

Value $268K Shares 13,097 Share Price $20.47 Est. Cost/Share $18.93 Unrealized @ Report Date +6.5%

CMPX COMPASS THERAPEUTICS INC 0.8%

Value $187K Shares 53,503 Share Price $3.50 * Est. Cost/Share $3.22 Unrealized @ Report Date -1.9%

BCAX BICARA THERAPEUTICS INC 0.8%

Value $173K Shares 10,941 Share Price $15.79 * Est. Cost/Share $25.50 Unrealized @ Report Date -56.1%

KYTX KYVERNA THERAPEUTICS INC 0.6%

Value $138K Shares 22,981 Share Price $6.00 * Est. Cost/Share $23.94 Unrealized @ Report Date -83.3%

LXEO LEXEO THERAPEUTICS INC 0.5%

Value $115K Shares 17,332 Share Price $6.64 * Est. Cost/Share $13.31 Unrealized @ Report Date -63.7%

IKT INHIBIKASE THERAPEUTICS INC 0.1%

Value $26,557 Shares 16,393 Share Price $1.62 * Est. Cost/Share $2.49 Unrealized @ Report Date -30.6%

SABS SAB BIOTHERAPEUTICS INC 0.1%

Value $21,979 Shares 10,935 Share Price $2.01 * Est. Cost/Share $2.26 Unrealized @ Report Date 0.0%

CNTX CONTEXT THERAPEUTICS INC 0.1%

Value $17,829 Shares 18,403 Share Price $0.97 * Est. Cost/Share $1.72 Unrealized @ Report Date -53.0%

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
RZLT	REZOLUTE INC	1,986,818	$18.68M	81.7%	$9.40 *	$8.14	-18.2%	COM NEW	76200L309
GLD	SPDR GOLD TR	7,286	$2.59M	11.3%	$355.47	$310.70	—	GOLD SHS	78463V107
BRK/B	BERKSHIRE HATHAWAY INC DEL	651	$327K	1.4%	$503.00 *	$401.81	+20.5%	CL B NEW	084670702
—	MIND MEDICINE MINDMED INC	27,011	$318K	1.4%	$11.79	$8.91	—	COM NEW	60255C885
ELVN	ENLIVEN THERAPEUTICS INC	13,097	$268K	1.2%	$20.47	$18.93	+6.5%	COM	29337E102
CMPX	COMPASS THERAPEUTICS INC	53,503	$187K	0.8%	$3.50 *	$3.22	-1.9%	COM	20454B104
BCAX	BICARA THERAPEUTICS INC	10,941	$173K	0.8%	$15.79 *	$25.50	-56.1%	COM	055477103
KYTX	KYVERNA THERAPEUTICS INC	22,981	$138K	0.6%	$6.00 *	$23.94	-83.3%	COM	501976104
LXEO	LEXEO THERAPEUTICS INC	17,332	$115K	0.5%	$6.64 *	$13.31	-63.7%	COM	52886X107
IKT	INHIBIKASE THERAPEUTICS INC	16,393	$26,557	0.1%	$1.62 *	$2.49	-30.6%	COM NEW	45719W205
SABS	SAB BIOTHERAPEUTICS INC	10,935	$21,979	0.1%	$2.01 *	$2.26	0.0%	COM NEW	78397T202
CNTX	CONTEXT THERAPEUTICS INC	18,403	$17,829	0.1%	$0.97 *	$1.72	-53.0%	COM	21077P108